<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ectrims on BEHIND-MS</title>
    <link>https://www.behind-ms.eu/en/tags/ectrims/</link>
    <description>Recent content in Ectrims on BEHIND-MS</description>
    <generator>Hugo</generator>
    <language>en</language>
    <lastBuildDate>Tue, 10 Nov 2026 00:00:00 +0000</lastBuildDate>
    <atom:link href="https://www.behind-ms.eu/en/tags/ectrims/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BEHIND-MS at ECTRIMS 2026</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2026/</link>
      <pubDate>Tue, 10 Nov 2026 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2026/</guid>
      <description>&lt;h1 id=&#34;behind-ms-at-ectrims-2026&#34;&gt;BEHIND-MS at ECTRIMS 2026:&lt;/h1&gt;&#xA;&lt;h2 id=&#34;can-understanding-ebv-help-us-move-towards-ms-prevention&#34;&gt;Can understanding EBV help us move towards MS prevention?&lt;/h2&gt;&#xA;&lt;p&gt;At ECTRIMS 2026, the session “&lt;em&gt;Towards MS prevention&lt;/em&gt;” explored an increasingly important question: if we better understand what happens before multiple sclerosis develops, could we eventually intervene earlier, or even prevent it?&lt;/p&gt;&#xA;&lt;p&gt;As part of the session, Prof. Christian Münz presented research from the BEHIND-MS project, providing new insights into how Epstein-Barr virus (EBV) could contribute to inflammation and damage in the central nervous system.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS Annual Meeting 2025</title>
      <link>https://www.behind-ms.eu/en/news/2025-11-12/</link>
      <pubDate>Wed, 12 Nov 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2025-11-12/</guid>
      <description>&lt;h2 id=&#34;behind-ms-annual-meeting-2025-advancing-research-on-epstein-barr-virus-and-multiple-sclerosis&#34;&gt;BEHIND-MS Annual Meeting 2025: Advancing Research on Epstein-Barr Virus and Multiple Sclerosis&lt;/h2&gt;&#xA;&lt;p&gt;From 10–11 November 2025, partners of the BEHIND-MS project gathered in Heidelberg, Germany, for the annual consortium meeting, hosted at the German Cancer Research Center (DKFZ). The meeting brought together leading scientists, clinicians, and patient engagement experts from across Europe to discuss the project’s progress and next steps in uncovering the complex links between Epstein-Barr virus (EBV) infection and multiple sclerosis (MS).&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS at ECTRIMS 2025</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025-au/</link>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025-au/</guid>
      <description>&lt;p&gt;At this year’s &lt;a href=&#34;https://ectrims.eu/ectrims2025/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ECTRIMS Congress&lt;/a&gt;&#xA; in Barcelona (24–26 September 2025), the EU Horizon-funded consortia &lt;a href=&#34;https://www.behind-ms.eu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BEHIND-MS&lt;/a&gt;&#xA; made a powerful contribution to advancing our understanding of the Epstein-Barr virus (EBV) and its potential role in multiple sclerosis (MS). Through a series of oral and poster presentations, educational sessions, and collaborative meetings, BEHIND-MS researchers shared groundbreaking findings that shed light on how EBV infection, immune dysregulation, and genetic susceptibility intersect in MS.&#xA;The consortium’s strong presence at ECTRIMS highlighted not only scientific excellence but also the importance of collaboration across Europe to accelerate discovery and move closer to prevention and better outcomes for people with MS.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Breaking Ground on EBV and MS</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025-bg/</link>
      <pubDate>Tue, 28 Oct 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025-bg/</guid>
      <description>&lt;p&gt;At this year’s &lt;a href=&#34;https://ectrims.eu/ectrims2025/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ECTRIMS Congress&lt;/a&gt;&#xA; in Barcelona (24–26 September 2025), the EU Horizon-funded consortia &lt;a href=&#34;https://www.behind-ms.eu/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;BEHIND-MS&lt;/a&gt;&#xA; and &lt;a href=&#34;https://www4.uib.no/en/research/research-projects/ebv-ms&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;EBV-MS&lt;/a&gt;&#xA; joined forces to host a highly engaging educational session titled: &lt;em&gt;“Epstein-Barr Virus in Multiple Sclerosis: Where are we? Where should we go?”&lt;/em&gt;&lt;/p&gt;&#xA;&lt;p&gt;The session explored the emerging evidence on the role of Epstein-Barr virus (EBV) in multiple sclerosis (MS) and examined how this knowledge could guide future prevention and treatment strategies.&lt;/p&gt;&#xA;&lt;p&gt;The session was chaired by &lt;strong&gt;Prof. Jan Lünemann&lt;/strong&gt; (University of Münster, BEHIND-MS consortium), &lt;strong&gt;Prof. Marianna Cortese&lt;/strong&gt; (Harvard T.H. Chan School of Public Health in Boston, EBV-MS consortium), and &lt;strong&gt;Prof. Øivind Torkildsen&lt;/strong&gt; (University of Bergen, EBV-MS consortium).&lt;/p&gt;</description>
    </item>
    <item>
      <title>Educational Session at ECTRIMS 2025</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2025/</link>
      <pubDate>Tue, 06 May 2025 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2025/</guid>
      <description>&lt;p&gt;We are excited that this year’s ECTRIMS congress, taking place in Barcelona from the September 24-26, will feature an educational session on the &lt;strong&gt;“Epstein Barr-Virus in Multiple Sclerosis: Where are we? Where should we go?”&lt;/strong&gt; chaired by Dr. Jan Lünemann from Münster and Dr. Marianna Cortese from Boston. This educational session will take place September 24 from 8:30 to 9:30 am and will be a joint initiative between &lt;a href=&#34;https://www.behind-ms.eu/en&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;the BEHIND-MS project&lt;/a&gt;&#xA; and &lt;a href=&#34;https://www.uib.no/en/ebvms&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;the EBV-MS project&lt;/a&gt;&#xA;, two ambitious EU-funded consortia focused on elucidating the role of EBV infection in the onset and progression of MS.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS at ECTRIMS 2024</title>
      <link>https://www.behind-ms.eu/en/news/2024-10-18/</link>
      <pubDate>Fri, 18 Oct 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/2024-10-18/</guid>
      <description>&lt;h1 id=&#34;behind-ms-at-ectrims-2024-highlighting-cutting-edge-research-and-patient-engagement&#34;&gt;BEHIND-MS at ECTRIMS 2024: Highlighting Cutting-Edge Research and Patient Engagement&lt;/h1&gt;&#xA;&lt;p&gt;The BEHIND-MS project had a strong presence at &lt;a href=&#34;https://ectrims.eu/ectrims2024/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;ECTRIMS 2024&lt;/a&gt;&#xA;, Europe&amp;rsquo;s leading multiple sclerosis (MS) research conference. Our participation spanned a variety of key activities, from cutting-edge scientific presentations to engaging with the MS community and researchers at our booth. This year, the focus was on the critical advancements in MS research and the promotion of resources aimed at empowering patients and professionals alike.&lt;/p&gt;</description>
    </item>
    <item>
      <title>BEHIND-MS partners at ECTRIMS 2024</title>
      <link>https://www.behind-ms.eu/en/news/ectrims-2024/</link>
      <pubDate>Thu, 29 Aug 2024 00:00:00 +0000</pubDate>
      <guid>https://www.behind-ms.eu/en/news/ectrims-2024/</guid>
      <description>&lt;h2 id=&#34;ectrims-2024&#34;&gt;ECTRIMS 2024&lt;/h2&gt;&#xA;&lt;p&gt;Our BEHIND-MS partner, Dr. Roberta Magliozzi, will be co-chairing the ‘Scientific Session 9: Barriers and lymphatics of the brain’ at ECTRIMS 2024 - the Congress of the European Committee for Treatment and Research in Multiple Sclerosis.&lt;/p&gt;&#xA;&lt;p&gt;The session will include_&lt;/p&gt;&#xA;&lt;ul&gt;&#xA;&lt;li&gt;&#xA;&lt;p&gt;A presentation from Dr. Marvin van Luijn, BEHIND-MS partner from Erasmus MC – MS Center ErasMS, on “Breaking barriers: scrutinizing T cells that act at the forefront in people with MS”.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
